Suppr超能文献

新型冠状病毒肺炎疫苗:当前临床试验安全性与有效性综述

COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials.

作者信息

Yan Zhi-Peng, Yang Ming, Lai Ching-Lung

机构信息

Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong 999077, China.

Department of Ophthalmology, The University of Hong Kong, Hong Kong 999077, China.

出版信息

Pharmaceuticals (Basel). 2021 Apr 25;14(5):406. doi: 10.3390/ph14050406.

Abstract

Various strategies have been designed to contain the COVID-19 pandemic. Among them, vaccine development is high on the agenda in spite of the unknown duration of the protection time. Various vaccines have been under clinical trials with promising results in different countries. The protective efficacy and the short-term and long-term side effects of the vaccines are of major concern. Therefore, comparing the protective efficacy and risks of vaccination is essential for the global control of COVID-19 through herd immunity. This study reviews the most recent data of 12 vaccines to evaluate their efficacy, safety profile and usage in various populations.

摘要

为控制新冠疫情已制定了各种策略。其中,尽管保护期时长未知,但疫苗研发仍是重中之重。不同国家已有多种疫苗正在进行临床试验,结果令人鼓舞。疫苗的保护效力以及短期和长期副作用是主要关注点。因此,比较疫苗接种的保护效力和风险对于通过群体免疫实现全球新冠疫情控制至关重要。本研究回顾了12种疫苗的最新数据,以评估它们在不同人群中的效力、安全性概况及使用情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/622b/8144958/979275151bde/pharmaceuticals-14-00406-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验